Ingersoll Rand Earnings Reports

Ingersoll Rand posted strong Q4 2024 results, with revenue growing 4.2% year-over-year to $1.90 billion. Net income remained stable at $229.8 million, while adjusted EPS declined slightly to $0.84. Free cash flow was strong at $490.9 million, reflecting a 25.9% margin. The Precision & Science Technologies segment drove revenue growth, while the Industrial Technologies & Services segment remained flat.

Ingersoll Rand reported a strong third quarter in 2024, with record orders and revenue. The company's performance was driven by its competitive differentiator, Ingersoll Rand Execution Excellence (IRX).

Ingersoll Rand reported strong Q2 2024 results, with revenue up 7% to $1.805 billion and adjusted EPS at $0.83. The company is raising full-year guidance for revenue, Adjusted EBITDA, and Adjusted EPS based on this performance and expectations for continued strength.

Ingersoll Rand reported a strong start to 2024 with record first-quarter revenue of $1,670 million, up 3% year-over-year. Adjusted EBITDA increased by 15% to $459 million, with a margin of 27.5%. Adjusted EPS was $0.78. The company raised its full-year Adjusted EBITDA and Adjusted EPS guidance.

Ingersoll Rand reported a strong fourth quarter in 2023, with revenue up 12% and adjusted EBITDA up 19%. The company's performance was driven by its competitive differentiator, Ingersoll Rand Execution Excellence (IRX).

Ingersoll Rand reported a strong third quarter with a 15% increase in revenue to $1.739 billion and a 23% increase in adjusted EBITDA to $462 million. The company raised its full-year guidance for total revenue growth, organic revenue growth, Adjusted EBITDA, and Adjusted EPS.

Ingersoll Rand reported a strong second quarter in 2023, achieving record orders and revenue. The company raised its full-year guidance for total revenue growth, organic revenue growth, Adjusted EBITDA, and Adjusted EPS due to the outstanding performance.

Ingersoll Rand reported a strong start to 2023 with record first-quarter orders and revenue, driven by solid execution and its economic growth engine. The company raised its full-year guidance for organic revenue growth, adjusted EBITDA, and adjusted EPS ranges based on robust Q1 performance. The company remains guided by its five strategic imperatives, which enable Ingersoll Rand to be a premier earnings compounder.

Ingersoll Rand reported record fourth quarter and full year 2022 results. The company's Q4 revenue was $1,624 million, up 14%, and adjusted EBITDA was $420 million, up 23%.

Ingersoll Rand reported a record third quarter with strong growth across multiple metrics, driven by agility and commitment to operational excellence. The company announced six strategic bolt-on acquisitions and raised full-year 2022 guidance.

Ingersoll Rand reported a strong second quarter with record orders and revenue, driven by strong organic growth and improved profitability. The company is raising its full-year 2022 organic revenue growth expectation and Adjusted EBITDA range.

Ingersoll Rand reported record first-quarter orders and revenue, driven by its competitive differentiator, Ingersoll Rand Execution Excellence (IRX). The company is raising its full-year 2022 organic revenue growth expectation and Adjusted EBITDA range.

Ingersoll Rand reported a strong fourth quarter in 2021, with record orders and revenue. The company's performance was driven by its strategic imperatives and the successful navigation of supply chain and inflationary challenges. Looking ahead, Ingersoll Rand is well-positioned for continued success in 2022.

Ingersoll Rand reported record orders and revenue in Q3 2021, driven by disciplined execution and capital allocation. The company raised its full-year 2021 revenue growth and Adjusted EBITDA guidance.

Ingersoll Rand reported a strong second quarter with record double-digit growth in both orders and revenue. The company's performance was driven by the Ingersoll Rand Execution Excellence (IRX) strategy. Due to continued strong performance, the company is raising its full-year 2021 revenue growth and Adjusted EBITDA guidance.

Ingersoll Rand reported a strong first-quarter performance in 2021, driven by the transformative power of IRX. The company saw a 17% increase in revenues and a 29% increase in orders, with organic growth of 12% and 24% respectively. The company is raising its 2021 full year guidance.

Ingersoll Rand reported Q4 revenues of $1.5 billion, a 149% increase versus the prior year. Net income attributable to Ingersoll Rand was $152 million, or $0.36 per share. Adjusted EBITDA was $344 million, up 10% from the prior year, with an Adjusted EBITDA margin of 22.8%. The company executed approximately $175 million of annualized Transaction-related cost synergies.

Ingersoll Rand reported Q3 2020 revenues of $1.3 billion, a 124% increase compared to the prior year. Net income attributable to Ingersoll Rand Inc. was $30 million, or $0.07 per share. Adjusted EBITDA was $284 million with a margin of 21.3%. The company executed approximately $150 million of annualized cost synergies.

Ingersoll Rand reported second-quarter revenues of $1.3 billion, a 101% increase compared to the previous year. The company's adjusted EBITDA was $241 million with a margin of 19.1%. Despite challenging market conditions, Ingersoll Rand emphasized strong free cash flow and liquidity.

Ingersoll Rand reported first-quarter revenues of $800 million, up 29% due to the Transaction. However, the company reported a net loss of $37 million, or a loss of $0.13 per share. Supplemental Adjusted EBITDA was $208 million with a margin of 16.4%. Due to the uncertainty of current economic conditions associated with COVID-19 and its impact on end markets, Ingersoll Rand is not providing 2020 guidance at this time.

Gardner Denver reported Q4 2019 results with revenues of $606 million, a decrease of 15% compared to the prior year. Net income was $26 million, or $0.12 per share. Adjusted EBITDA was $135 million with a margin of 22.3%. The company generated $90 million in free cash flow.